No abstract available
MeSH terms
-
Adalimumab
-
Amphotericin B / therapeutic use*
-
Animals
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Antiprotozoal Agents / therapeutic use
-
Antirheumatic Agents / adverse effects*
-
Female
-
Humans
-
Leishmania infantum
-
Leishmaniasis, Cutaneous / chemically induced*
-
Leishmaniasis, Cutaneous / drug therapy*
-
Middle Aged
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antiprotozoal Agents
-
Antirheumatic Agents
-
Tumor Necrosis Factor-alpha
-
Amphotericin B
-
Adalimumab